drugset / Trial / NCT00274066

Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva

NCT00274066

Phase 3 Completed 65 enrolled Boehringer Ingelheim
RandomizedCrossoverDouble-blindTreatment

Summary

To evaluate acute effect of single dose of ipratropium (Atrovent) or fenoterol (Berotec) in comparison to placebo when given to COPD patients on pharmacodynamic steady state of tiotropium (Spiriva)

Timeline

Start
2002-10
Primary completion
2003-09
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenoterol Unknown 200 ug Inhaled
Subject Ipratropium Small molecule 40 ug Inhaled
Background Tiotropium Other / unclassified 18 ug Inhaled